http://www.exac.com News daily 1 2007-11-26T15:37:37Z http://www.exac.com/news/exactech-to-present-to-investors-at-baird2019s-2008-small-cap-healthcare-conference GAINESVILLE, Fla. -- September 8, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at Baird's 2008 Small Cap Healthcare Investor Conference on September 10 in New York. No publisher kmiranda Press Releases 2008-09-09T13:50:36Z News Item http://www.exac.com/news/exactech-to-present-at-the-2008-noble-financial-equity-conference-on-august-18 GAINESVILLE, Fla. -- August 5, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Fourth Annual Noble Financial Equity Conference. The two-day conference will showcase 150 small cap public companies at the Loews Lake Las Vegas Resort, Nevada. No publisher jhamilton Press Releases 2008-08-13T13:28:40Z News Item http://www.exac.com/news/exactech-q2-revenue-up-38-to-43.7m-net-income-3.0m-vs-1.4m GAINESVILLE, Fla. -- July 30, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that revenue for the second quarter of 2008 increased 38% to $43.7 million from $31.6 million in the second quarter of 2007. Diluted earnings per share for the quarter was $0.24 based on net income of $3.0 million. This compares with net income of $1.4 million or $0.12 diluted EPS a year ago. No publisher lnorthsea Press Releases 2008-08-13T14:18:55Z News Item http://www.exac.com/news/exactech-awarded-national-contract-from-healthtrust-purchasing-group-for-orthopaedic-products GAINESVILLE, Fla. -- July 29, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it has been awarded a national purchasing contract by HealthTrust Purchasing Group (HealthTrust). This contract will cover the Equinoxe® Shoulder product line. The award is a three-year agreement that goes into effect August 1, 2008. No publisher lnorthsea Press Releases 2008-07-29T13:18:43Z News Item http://www.exac.com/news/exactech-announces-q2-earnings-and-conference-call GAINESVILLE, Fla. -- July 16, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its second quarter earnings on Wednesday, July 30, after the market closes. No publisher lnorthsea Press Releases 2008-08-13T13:29:05Z News Item http://www.exac.com/news/exactech-joins-russell-3000-index GAINESVILLE, Fla. -- July 1, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it was added to the broad-market Russell 3000 Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes. The Russell 3000 Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization. The final membership list for the Russell 3000 has been posted at www.russell.com/Indexes/membership/default.asp. No publisher lnorthsea Press Releases 2008-08-13T13:31:21Z News Item http://www.exac.com/news/exactech-awarded-national-contract-from GAINESVILLE, Fla. -- June 18, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it was awarded a national purchasing contract by HealthTrust Purchasing Group, LP (HealthTrust). This contract will include primary and revision hip and knee implants, as well as InterSpace® cement spacers. The award is a five-year agreement that goes into effect July 15th. No publisher lnorthsea Press Releases 2008-08-13T13:32:12Z News Item http://www.exac.com/news/exactech-signs-new-40-million-revolving-line-of GAINESVILLE, Fla. -- June 16, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it has signed a new $40 million syndicated line of credit. No publisher lnorthsea Press Releases 2008-08-13T13:32:47Z News Item http://www.exac.com/news/exactech-expands-total-hip-replacement-offerings GAINESVILLE, Fla. -- June 13, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the full-market release of the Novation® Crown Cup® Acetabular System, the latest component of the Novation Comprehensive Hip System. No publisher lnorthsea Press Releases 2008-08-13T13:33:17Z News Item http://www.exac.com/news/exactech-announces-leadership-promotions GAINESVILLE, Fla. -- June 3, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today several key leadership promotions. No publisher lnorthsea Press Releases 2008-08-13T13:34:01Z News Item http://www.exac.com/news/exactech-completes-previously-announced-sale-of GAINESVILLE, Fla. -- May 14, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it has closed its previously announced sale of 877,391 shares of its common stock to certain institutional investors at a price of $23.00 per share. The sale resulted in gross proceeds of approximately $20.2 million and net proceeds of approximately $18.8 million after offering expenses and placement agency fees. Exactech offered the shares pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. No publisher lnorthsea Press Releases 2008-08-13T13:34:52Z News Item http://www.exac.com/news/exactech-announces-sale-of-common-stock-resulting GAINESVILLE, Fla. -- May 9, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it has entered into definitive agreements with certain institutional investors to sell 877,391 shares of its common stock at a price of $23.00 per share, resulting in gross proceeds of approximately $20.2 million and net proceeds of approximately $18.8 million after offering expenses and placement agency fees. Exactech offered the shares pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. The offering is expected to close on or before May 14, 2008 and is subject to certain closing conditions. No publisher lnorthsea Press Releases 2008-08-13T13:36:28Z News Item http://www.exac.com/news/exactech-increases-q1-and-fy201908-financial-1 GAINESVILLE, Fla. -- April 29, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $39.8 million for the first quarter of 2008, an increase of 34% compared to $29.6 million for the first quarter of 2007. Net income for the quarter was $2.8 million, or $0.23 per diluted share, a gain of 49% from the $1.9 million, or $0.16 per diluted share, in the same quarter a year ago. First quarter diluted earnings per share included a gain of $0.03 due to a forward currency call option and a loss of $0.01 per share due to Exactech’s minority investment in Altiva prior to the acquisition. No publisher lnorthsea Press Releases 2008-08-13T14:12:26Z News Item http://www.exac.com/news/exactech-increases-q1-and-fy201908-financial GAINESVILLE, Fla. -- April 10, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it expects to report revenue of approximately $40.0 million for the first quarter of 2008, an increase of 35% compared to $29.6 million for the first quarter of 2007. Diluted earnings per share for the first quarter is expected to range from $0.22 to $0.24 compared with $0.16 diluted earnings per share in the same quarter a year ago. First quarter earnings include a gain of $0.03 due to a forward currency call option. No publisher lnorthsea Press Releases 2008-08-13T13:38:00Z News Item http://www.exac.com/news/exactech-closes-france-medica-acquisition GAINESVILLE, Fla. -- April 7, 2008 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that, effective April 1, 2008, it closed on the acquisition of the stock and assets of France Medica SAS, a French importer and distributor of orthopaedic products and surgical supplies. No publisher lnorthsea Press Releases 2008-08-13T13:38:31Z News Item